Drs. Carry and Vasilatis presented their innovations and questions to the innovative minds of Boehringer Ingelheim, an insightful experience focused on regulatory pathways and navigating the drug discovery space.
Zena founders attend Boehringer Ingelheim 2022 Office hours
Previous
Previous
Zena Tx partners with Rutgers and is awarded Catalyst R&D Voucher Program from CSIT
Next
Next

